ASN Critical Care Nephrology – 2022 Update (On-Demand and Livestream)

Designed for trainees, practicing nephrologists, and other nephrology providers who care for critically ill patients with kidney diseases, this program reviews principles of critical care nephrology and provides updates on the latest developments. Presentations review topics in critical care medicine relevant to nephrology providers, which include hemodynamic monitoring and support; fluid optimization; extracorporeal techniques for sepsis; ethical issues; and management of dysnatremias, acute respiratory distress syndrome, and COVID-19.

Presentations also focus on management of critically ill patients with AKI, including such specific populations as patients who are pregnant and those with liver disease, heart failure, or cancer. In addition, the program covers the short- and long-term outcomes of AKI, how to manage patients with AKI and persistent dialysis needs, and key considerations when prescribing RRT. Many presentations use instructive cases.

Course Objective(s)

Upon completion of the program, the participant will be able to:

1) describe evidence-based approaches to the management of shock

2) synthesize the diagnosis and management of AKI in specific populations, including patients with cardiorenal syndrome, liver disease, pregnancy, hypertensive emergencies, and cancer

3) discuss the current management of COVID-19 infection in the ICU setting

4) analyze the current evidence for the clinical use of biomarkers for AKI

5) discuss the current evidence for extracorporeal techniques for sepsis

6) describe the long-term complications for patients who survive an episode of AKI

7) evaluate the most appropriate dose and prescription of RRT for critically ill patients with AKI.

Content 

On Demand 

Presentations

• A Practical Approach to Vasopressors and Inotropes in Shock
  Michael J. Connor, MD
  
• Fluids as Drugs
  Ravindra L. Mehta, MBBS, MD, FASN
  
• Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock
  J. Pedro Teixeira, MD
  
• Biomarkers for AKI
  Dennis G. Moledina, MD, PhD, FASN
  
• Assessment of Point-of-Care Ultrasound Use in the Critical Care Unit
  Abhilash Koratala, MD, FASN
  
• Diagnosis and Management of Dysnatremias in the ICU: A Case-Based Approach
  Javier A. Neyra, MD, MS, FASN
  
• Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation Therapy: A Primer for Nephrology Providers
  Ankur Srivastava, MD
  
• Ethics: When Can You Say No?
  Holly M. Koncicki, MD, MS
  
• Update on COVID-19 in Critically Ill Patients
  Amanda Dijanic Zeidman, MA, MD
  
• AKI in Liver Disease
  Luis A. Juncos, MD, FASN
  
• Cardiorenal Syndrome
  Janani Rangaswami, MD
  
• Year in Review: Critical Care
  Kathleen D. Liu, MD, PhD, FASN
  
• Case-Based Approach to Patients with AKI and Hypertensive Emergencies
  Pedram Fatehi, MD, MPH
  
• AKI and Cancer
  Anushree C. Shirali, MD
  
• AKI in Pregnant Patients: What Practitioners Need to Know
  Jessica Sheehan Tangren, MD, MPH, FASN
  
• Long-Term AKI Outcomes and Follow-Up
  Edward D. Siew, MD, MS
  
• Management of Outpatients with AKI Requiring RRT
  Michael Heung, MD, MS, FASN
  
• Timing of RRT in AKI
  Jay L. Koyner, MD
  
• Dosing and Modality of RRT
  Paul M. Palevsky, MD, FASN
  
• Using Prolonged Intermittent RRT in the ICU: When and How to Prescribe It
  Anitha Vijayan, MD, FASN
  
• Evidence for Extracorporeal Purification Techniques for Sepsis
  Amanda Dijanic Zeidman, MA, MD
  
• Drug Dosing in AKI, Including the Impact of RRT
  Linda Awdishu, PharmD, FASN
  
• Advanced CRRT Practices: A Case-Based Approach
  Ashita J. Tolwani, MD, MS, MSc

Livestream

Presentations

• Welcome and Introduction – Co-Chairs
  02:00 PM EDT – 02:05 PM EDT
  
• Balanced Solutions Should Be the Fluid of First Choice in Critical Care Units – PRO
  02:05 PM EDT – 02:40 PM EDT
  Michael J. Connor, MD
  
• Balanced Solutions Should Be the Fluid of First Choice in Critical Care Units – CON
  02:40 PM EDT – 03:15 PM EDT
  Luis A. Juncos, MD, FASN
  
• Rebuttals
  03:15 PM EDT – 03:25 PM EDT
  
• Closing Remarks – Co-Chairs
  03:25 PM EDT – 03:30 PM EDT